Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Scott Carlyle Morgan"'
Autor:
Aly-Khan A. Lalani, Anand Swaminath, Gregory Russell Pond, Scott Carlyle Morgan, Arun Azad, William Chu, Eric Winquist, Anil Kapoor, Michael Bonert, Jonathan L. Bramson, Michael G. Surette, Christina M. Canil, Shankar Siva, Georg A. Bjarnason, Mark Norman Levine, Jim Wright, Sebastien J. Hotte
Publikováno v:
Journal of Clinical Oncology. 41:TPS750-TPS750
TPS398 Background: Randomized data from the interferon era demonstrated survival benefits of cytoreductive nephrectomy (CN) in patients with metastatic renal cell carcinoma (mRCC). Results from SURTIME and CARMENA, conducted in the VEGF-targeted ther
Autor:
William James Phillips, Alborz Jooya, Roshanak Mahdavi, Jennifer Leigh, Karine Tawagi, Colleen Webber, Christina Milani, Scott Carlyle Morgan, Robert Malcolm MacRae, Jean-Marc Bourque, Peter Tanuseputro, Michael Ong
Publikováno v:
Journal of Clinical Oncology. 40:e17043-e17043
e17043 Background: Palliative bone radiation is the predominant skeletal-related event (SRE) reported in advanced prostate cancer. Bone targeted agents (BTA), such as denosumab and zoledronic acid, are shown to both prevent and delay SREs including b
Autor:
Shawn Malone, Christopher J.D. Wallis, Richard M. Lee-Ying, Naveen S. Basappa, Ilias Cagiannos, Robert James Hamilton, Ricardo Fernandes, Cristiano Ferrario, Geoffrey Gotto, Scott Carlyle Morgan, Chris Morash, Tamim Niazi, Krista Noonan, Ricardo A. Rendon, Sebastien J. Hotte, Fred Saad, Anousheh Zardan, Brendan Osborne, Katherine Chan, Bobby Shayegan
Publikováno v:
Journal of Clinical Oncology. 40:53-53
53 Background: To describe patterns of practice of PSA testing and imaging for Ontario men receiving continuous androgen deprivation therapy (ADT) for the treatment of non-metastatic castration-resistant prostate cancer (nmCRPC). Methods: This was a